NCT06150586

Brief Summary

Primary aims of the study are to evaluate the feasibility of Skin conductance (SC) measurements and its correlation to Neonatal Pain and Distress Scale (N-PASS) - scores during the Less-Invasive-Surfactant-Administration (LISA)-procedure in preterm infants. Secondary aims are to evaluate the effect of LISA on the general stress-level in preterm infants with respiratory distress syndrome. The assessment of pain and stress with SC measurement in addition to the subjective assessment with N-PASS may provide more conclusive data on the sensation of pain or stress during the LISA procedure and therefore the necessity of analgosedation. Therefore, this study might help to identify those infants in need for analgosedation, which would allow an individualized approach in the future.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 20, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 29, 2023

Completed
6 days until next milestone

Study Start

First participant enrolled

December 5, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 14, 2024

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 17, 2024

Completed
Last Updated

February 10, 2026

Status Verified

February 1, 2026

Enrollment Period

6 months

First QC Date

November 20, 2023

Last Update Submit

February 5, 2026

Conditions

Keywords

Less-Invasive-Surfactant-AdministrationSkin ConductanceNeonatal Pain and Sedation ScaleAnalgosedationGeneral stress-level

Outcome Measures

Primary Outcomes (1)

  • Median peaks per second at prespecified time-points adjusted for median peaks per second at baseline

    The prespecified time-points are: 1. baseline: before starting of interventions (2 minutes recording without any intervention); 2. insertion of nasopharyngeal tube; 3. insertion of laryngoscope for visualization of the vocal cords; 4. insertion of LISA catheter 5. administration of surfactant 6. removal of catheter 7. 5 minutes after removal of catheter (2 minutes recording without any intervention) 8. 1 hour (±10 minutes) after LISA (2 minutes recording without any intervention)

    2 minutes before LISA, during LISA, 1 hour (±10 minutes) after LISA

Secondary Outcomes (24)

  • Median Neonatal Pain, Agitation and Sedation Scale (N-PASS) at prespecified time-points, adjusted for median N-PASS at baseline

    2 minutes before LISA, during LISA, 1 hour (±10 minutes) after LISA

  • Absolute number of apneas

    During LISA procedure

  • Absolute number of desaturations

    During LISA procedure

  • Absolute number of bradycardia

    During LISA procedure

  • Absolute number of arterial hypotension

    During LISA procedure

  • +19 more secondary outcomes

Study Arms (1)

Preterm infants with minimal gestational age of 27 weeks requiring LISA

LISA will be preformed according to our local standard protocol while measuring skin conductance via a specific monitor. At the same time a video is recorded for later unblinded and blinded N-PASS assessment.

Other: Skin Conductance (SC) MeasurementOther: Video Recording

Interventions

SC will be measured using a specific monitor and three self-adhesive electrodes on one foot of the infant (one plantar and two on the ankles). Peaks per second (the rate of firing in the sympathetic nerves), average amplitude (mean peaks) and area under curve (forcefulness of sympathetic nerve firing) will be automatically analyzed. Corresponding data will be transferred to a separate tablet computer via bluetooth.

Preterm infants with minimal gestational age of 27 weeks requiring LISA

The video recording for later N-PASS assessment will be done by a camera fixed above the incubator / resuscitation unit, not interfering with the LISA procedure. The video will show the full body of the newborn as well as the hands / forearms of the treating clinical team with the awareness and oral consent of the treating team.

Preterm infants with minimal gestational age of 27 weeks requiring LISA

Eligibility Criteria

AgeUp to 48 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

All preterm infants with ≥27 0/7 weeks of gestation at birth who meet the inclusion criteria and who do not fulfill the exclusion criteria

You may qualify if:

  • Preterm infants ≥27 0/7 weeks of gestation at birth
  • Need for surfactant therapy via LISA according to the local standard operating procedure
  • ≥27 0/7 weeks of gestation,
  • within first 48 hours of life
  • FiO2 ≥0.30 to maintain SpO2 ≥90% for 15 min,
  • non-invasive respiratory support with PEEP 6-8 cmH2O
  • consent of attending NICU staff for videorecording

You may not qualify if:

  • Primary intubation in the delivery room
  • Severe congenital malformation or other conditions requiring immediate endotracheal intubation
  • Insufficient language skills (German or English) of the parents to understand and consent the participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Zurich

Zurich, CH-8091, Switzerland

Location

Related Publications (9)

  • Peterson J, den Boer MC, Roehr CC. To Sedate or Not to Sedate for Less Invasive Surfactant Administration: An Ethical Approach. Neonatology. 2021;118(6):639-646. doi: 10.1159/000519283. Epub 2021 Oct 8.

    PMID: 34628413BACKGROUND
  • Tribolet S, Hennuy N, Snyers D, Lefebvre C, Rigo V. Analgosedation before Less-Invasive Surfactant Administration: A Systematic Review. Neonatology. 2022;119(2):137-150. doi: 10.1159/000521553. Epub 2022 Feb 4.

    PMID: 35124678BACKGROUND
  • Hummel P, Puchalski M, Creech SD, Weiss MG. Clinical reliability and validity of the N-PASS: neonatal pain, agitation and sedation scale with prolonged pain. J Perinatol. 2008 Jan;28(1):55-60. doi: 10.1038/sj.jp.7211861. Epub 2007 Oct 25.

    PMID: 18165830BACKGROUND
  • Hummel P, Lawlor-Klean P, Weiss MG. Validity and reliability of the N-PASS assessment tool with acute pain. J Perinatol. 2010 Jul;30(7):474-8. doi: 10.1038/jp.2009.185. Epub 2009 Nov 19.

    PMID: 19924132BACKGROUND
  • Munsters J, Wallstrom L, Agren J, Norsted T, Sindelar R. Skin conductance measurements as pain assessment in newborn infants born at 22-27 weeks gestational age at different postnatal age. Early Hum Dev. 2012 Jan;88(1):21-6. doi: 10.1016/j.earlhumdev.2011.06.010. Epub 2011 Jul 20.

    PMID: 21764228BACKGROUND
  • Storm H. Skin conductance and the stress response from heel stick in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2000 Sep;83(2):F143-7. doi: 10.1136/fn.83.2.f143.

    PMID: 10952711BACKGROUND
  • Storm H. Changes in skin conductance as a tool to monitor nociceptive stimulation and pain. Curr Opin Anaesthesiol. 2008 Dec;21(6):796-804. doi: 10.1097/ACO.0b013e3283183fe4.

    PMID: 18997532BACKGROUND
  • Morgan ME, Kukora S, Nemshak M, Shuman CJ. Neonatal Pain, Agitation, and Sedation Scale's use, reliability, and validity: a systematic review. J Perinatol. 2020 Dec;40(12):1753-1763. doi: 10.1038/s41372-020-00840-7. Epub 2020 Oct 2.

    PMID: 33009491BACKGROUND
  • Dirler C, Boos V, Bassler D, Benke-Bruderer S, Held U, Ruegger CM, Muehlbacher T. Pain Assessment During Less Invasive Surfactant Administration Using Skin Conductance: A Prospective Cohort Study. Pediatr Res. 2025 Dec 22. doi: 10.1038/s41390-025-04703-9. Online ahead of print.

MeSH Terms

Conditions

Infant, Premature, DiseasesRespiratory Distress SyndromePulmonary AtelectasisPain

Interventions

Weights and MeasuresVideotape Recording

Condition Hierarchy (Ancestors)

Infant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesLung DiseasesRespiratory Tract DiseasesRespiration DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Investigative TechniquesTape RecordingAudiovisual AidsEducational TechnologyTechnologyTechnology, Industry, and AgricultureTelevision

Study Officials

  • Dirk Bassler, MD

    Newborn Research, Department of Neonatology, University Hospital and University of Zurich

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 20, 2023

First Posted

November 29, 2023

Study Start

December 5, 2023

Primary Completion

June 14, 2024

Study Completion

June 17, 2024

Last Updated

February 10, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations